Clinical Trial

Additive Effects of Alternative Nostril Breathing with Pharmacological Management on Dyspnea and Control Pause in Patients with Bronchial Asthma

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 24, 2024 (before its estimated January 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Bronchial asthma is a widespread chronic condition charactrized by inflammation and narrowing of airways, leading to repeateted episodes of breathlessness, wheezing and labored breathing.Breathing exercises help to manage hyperventilation often seen in asthmatic patients. To handle respiratory complications asthmatics are advised to practise nasal breathing techniques in conjunction with their prescribed medications.
Trial Details
NCT Number NCT06609941
Lead Sponsor Foundation University Islamabad
Conditions Bronchial Asthma
Enrollment 32 participants
Start Date 2024-06-18
Primary Completion 2025-01-01 (estimated)
Study Completion 2025-02-01 (estimated)
Updated on ClinicalTrials.gov 2024-09-24